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Abstract
We hypothesize that specific bone marrow lineages and cytokine treatment may facilitate bone marrow migration into
islets, leading to a conversion into insulin producing cells in vivo. In this study we focused on identifying which bone
marrow subpopulations and cytokine treatments play a role in bone marrow supporting islet function in vivo by evaluating
whether bone marrow is capable of migrating into islets as well as converting into insulin positive cells. We approached this
aim by utilizing several bone marrow lineages and cytokine-treated bone marrow from green fluorescent protein (GFP)
positive bone marrow donors. Sorted lineages of Mac-1
+, Mac-1
2, Sca
+, Sca
2, Sca
2/Mac-1
+ and Sca
+/Mac-1
2 from GFP
positive mice were transplanted to irradiated C57BL6 GFP negative mice. Bone marrow from transgenic human ubiquitin C
promoter GFP (uGFP, with strong signal) C57BL6 mice was transplanted into GFP negative C57BL6 recipients. After eight
weeks, migration of GFP positive donor’ bone marrow to the recipient’s pancreatic islets was evaluated as the percentage of
positive GFP islets/total islets. The results show that the most effective migration comes from the Sca
+/Mac
2 lineage and
these cells, treated with cytokines for 48 hours, were found to have converted into insulin positive cells in pancreatic islets
in vivo. This study suggests that bone marrow lineage positive cells and cytokine treatments are critical factors in
determining whether bone marrow is able to migrate and form insulin producing cells in vivo. The mechanisms causing this
facilitation as well as bone marrow converting to pancreatic beta cells still need to be investigated.
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Introduction
Studies have shown that bone marrow transplantation contrib-
utes to the recovery of islet b cell function through differentiation
into islet b cells [1]. However, there are controversial arguments
regarding a failure to document such transdifferentiation or a very
low frequency of islet b cell differentiation [2]. Moreover, reports
on bone marrow correcting experimental hyperglycemia in
diabetic animals show that bone marrow initiates recipient b cell
regeneration through donor derived endothelial cells in the
pancreas rather than directly transdifferentiating into b cells [3],
but others showed no improvement in hyperglycemia after bone
marrow transplantation [4,5]. Although this controversy has yet
been resolved, bone marrow as a candidate for diabetes cell
therapy has been considered and explored [6–8].
In this study, we proposed to identify whether specific bone
marrow subpopulations and cytokine treatments play a critical role
in bone marrow migration to pancreatic islets and conversion into
islet cells in vivo. Specific populations of bone marrow can be
induced into forming pancreatic islet b cells [9–11] and cytokines
can be major regulators in influencing bone marrow conversion
into pancreatic islet cells [12]. However, it is important to know
which specific bone marrow population and cytokine treatment
regulates bone marrow migration (homing) into islets after
transplantation and whether migrated bone marrow can convert
into islet cells. In this manuscript, we attempted to address these
questions by testing GFP labeled bone marrow lineage cells in
colocalized pancreatic islets with insulin positive cells under the
following circumstances, a) GFP lineage cell populations from
bone marrow cells only and, b) GFP lineage cells pre-cultured with
cytokines, to evaluate whether these conditions facilitate bone
marrow migration and conversion into pancreatic islet cells after
transplantation.
Materials and Methods
Experimental Designs and Methods
Experimental Animals. C57BL/6-Tg (human ubiquitin C
promoter-GFP) 30Scha/J mice (uGFP) and BL6-Tg(ACTB-
EGFP)1Osb/J mice with an ‘‘enhanced’’ GFP (EGFP) cDNA,
under the control of a chicken beta-actin promoter and
cytomegalovirus enhancer (present in all tissues with the
exception of erythrocytes and hair) emitting green under light
excitation, were purchased from Jackson Laboratories (Bar
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in our animal facility with given ad libitum access to food and
water. The eGFP mice were pancreatic donors and the uGFP
mice were GFP labeled bone marrow donors. GFP negative
C57BL mice were the recipients. Animal study protocols were
approved by the Institutional Animal Care and Use Committee at
Roger Williams Hospital.
Bone Marrow Transplantation. 6–8 week old mice were used
as donors or recipients. After sacrificing the mice and dissecting the
femur, tibia and pelvic bones, bone marrow was obtained by flushing
the bones using a syringe and a 22-gauge needle with PBS containing
5% heat-inactivated fetal calf serum (HI-FCS). After re-suspension in
PBS without HI-FCS, cells were passed through a 40 mmc e l l
strainer. Cellnumbers were counted in crystal violet and viability was
assessed bytrypanblue staining.Whole bone marrowcellsorselected
populations of marrow cells, based on their surface markers, were
injected intravenously by tail vein into each recipient. The dose of the
cells infused was different in individual experiments and is mentioned
in the results section. A photon producing linear accelerator (Elekta)
was used for the radiation of recipient animalsbefore each transplant.
Radiation was given at a dose rate of 100 cGy per minute. The
recipients received 500 cGy of whole body.
Pancreas Collection and Immunohistochemistry
Staining. Specimens were collected after sacrificing the
anesthetized mice by cervical dislocation. Excised pancreatic
specimens were placed in freshly prepared PLP fixative solution
(balanced phosphate solution with 2% paraformaldehyde, sodium
m-periodate and L-lysine) for 2 hours at 4uC, with frequent
agitation. Samples were then washed in a 7% sucrose buffer
overnight followed by a 15% sucrose buffer wash for 2–3 hours and
a 25% sucrose plus 10% glycerol buffer wash for another 2 hours,
all at 4uC. They were then rinsed in PBS and embedded in tissue
freezing medium (OCT), frozen and stored at 270uC until
sectioning. Immunofluorescent staining was performed on 5
micron cryosections. For intracellular antigens, permeabilization
wasperformed with0.2% Triton X-100for 20 minutes, followed by
two PBS rinses. Sections were then blocked for 30 minutes with a
20% normal serum buffer. Sections were rinsed with PBS then
incubated with anti-proinsulin, insulin and biotinylated anti-mouse
CD45, rat monoclonal anti-CD34 (Abcam, Cambridge, MA) or
Alexa Fluor488 conjugated anti GFP antibodies (MolecularProbes,
Eugene, OR) for 2 hours at room temperature, followed by 1 hour
incubations with respective secondaries (Texas Red anti-guinea pig
for insulin, Rhodamine anti-mouse for proinsulin and Alexa Flour
streptavidin for CD45). GFP expression and antigens labeled by
different fluorescence-conjugated antibodies were visualized by
fluorescent microscopy (Axiovert w 135, Carl Zeiss, Oberko-chen,
Germany). Additional staining with non-fluorescent DAB and Blue
Figure 1.Weak GFP signals in pancreatic islet of eGFP transgenic C57BL6 mice. GFP signals in pancreatic islets of eGFP transgenic positive
mice were examined. A. Light microscopy image with the arrow indicating the tissue difference between a potential islet and the rest of the
pancreatic tissue. B. The area indicated by the arrow in islet shows weak green fluorescence vs. surrounding area. C. Immunohistochemistry with
insulin specific antibody indicated positive insulin cells (red) in islet but not yellow (mixture of green and red) and there is a CD45 cell (anti CD45
antibody blue) in the islet indicated by arrow. D. shows insulin positive cells only. E. shows weak GFP signals in islet areas vs. surrounding area. F.
shows CD 45 positive cell only. A and B image magnification: 65; C image magnification: 620; D–F image magnification: 640.
doi:10.1371/journal.pone.0004504.g001
Bone Marrow Sca Cells in Islet
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parallel sections were performed to confirm the fluorescent signals.
Cell Separation. Bone marrow was isolated from iliac bones,
femur, and tibiae of GFP transgenic mice 6 to 8 weeks of age.
Bone marrow cells were incubated with anti CD45-APC, anti c-
Kit APC and anti-Sca-1-biotin SA- APC (Pharmingen, San Diego,
CA). Cells positive and negative for individual markers were then
sorted into different tubes with a high speed MoFlow cell sorter
(Cytomation). For lineage negative separation, a low-density
fraction (,1.077 g/cm2) was isolated on Nycoprep 1.077A
(Accurate Chemical and Scientific Corporation). These cells
were lineage depleted using magnetic beads from a Lineage
Depletion kit (Miltenyi Biotec Inc. Auburn, CA). Cells were
washed and counted after depletion. The population of sorted cells
are displayed in Appendix S1.
Counting and Statistics. To count GFP positive islets in the
pancreas, 12 sections, 5 microns thick and 250 microns apart, were
made of each pancreatic specimen. The number of GFP positive
islets and the total islets in each section were counted. The ratio
between GFP positive islets and the total number of islets were
determined as percentage of GFP positive islets in total islets. Data
are presented as mean6one standard error of the mean. In the
text, table, and figures, all data are presented as means6SEM.
Most described experiments have been repeated three times.
However, for figures and tables, only one experiment of the results
is shown. Data used for graphical presentation and statistical
analysis are expressed as per experiment. Data were analyzed by
the ANOVA statistics program using a two factor analysis of
variance of repeated measures. Post hoc comparisons among
individual means were made by Tukey’s t-test.
Results
GFPs are expressed in the pancreatic islets of uGFP
transgenic mice and hematopoietic cells distribution in
the pancreas
We detected weak signals of GFP in the pancreatic islet area of
eGFP transgenic mice (Figure 1.). Un-homomorphy of GFP
signals were found in (A) and (B) and these insulin positive areas
were confirmed by fluorescent immunohistochemistry. There are
significantly strong GFP positive expression in areas surrounding
the insulin positive islet and CD45
+ (C). The images further
display individual channels for insulin (D), GFP (E) and CD45
+ (F).
GFP signals in uGFP transgenic mice are much stronger (Figure 2.)
than GFP signals in pancreatic islet from eGFP transgenic mice
(Figure 1). Since the pancreas is a more bone marrow resistant
organ, there are low numbers of hematopoietic cells in the
pancreas (about 4,5/ 1000 pancreatic cells) as shown in Figure 3
(A) and (B), compared with an abundance of hematopoietic cells
found in spleen (C) and (D). This suggests that bone marrow is
more likely to home into the spleen than to the pancreas.
Bone marrow cells migrate to pancreatic islets after
transplantation
Utilization of uGFP transgenic mice as bone marrow donors
allowed for tracking the labeled bone marrow migration into the
recipient’s pancreatic islets after transplantation (bone marrow
25610
6 cells) after 500 cGy (TBI). We found that infused bone
marrow homes to the pancreatic islets, as indicated by anti insulin
immunohistochemistry. These cells are also CD45 negative
(Figure 4 A) and CD34 positive (B).
Figure 2. GFP expresses in pancreatic islet in uGFP transgenic C57BL6 mice. Clear GFP signals in pancreatic islets have been shown via
immunohistochemistry of pancreatic sections from uGFP transgenic mice. A. Islet b cells have been identified by anti-insulin antibody (red, large
arrow indicated) and the positive insulin islet mixture with green GFP fluorescence (small arrow indicated) combination color image; B. Islet b cells
(red, arrows indicated) in red color image only; C. Nuclear staining with DAPI blue in blue color only; D. Positive GFP green in islet area (arrow
indicated) in green color only, image magnification: 640.
doi:10.1371/journal.pone.0004504.g002
Bone Marrow Sca Cells in Islet
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pancreatic islets
Lineage GFP positive bone marrow cells were isolated as
described above in methods and 2.5610
5/ml cells were infused
into recipients after 500 cGy irradiation. The positive GFP cells in
pancreatic islets were analyzed 8 weeks after transplantation.
There were six different cell lineages tested and whole bone
marrow (WBM) was used as a control. The results show that the
most favorable bone marrow population for migration to the islets
is Mac-12/Sca+ vs. WBM (Figure 5, *=p,0.01).
Figure 3. Distribution of CD45 cells in the pancreas and spleen of GFP negative mice. Identification of CD45+ cell migration into the
pancreas and spleen was performed in GFP negative C57BL6 mice. A. Pancreatic tissue as negative control for immunohistochemistry with anti-CD45
specific antibody. B. CD45+ cells were found in pancreas (brown indicated by black arrow). CD45+ population in pancreas was about 4,5/1000
pancreatic cells. C. Negative control of spleen. D. Spleen contains a large number of CD45+ cells 600,700/1000 spleen cells while the amounts of
bone marrow cells in pancreatic tissue (B) were low. Image magnification: 65.
doi:10.1371/journal.pone.0004504.g003
Figure 4. uGFP positive cell distribution in islet is CD 45 negative, but CD34 positive. A. Fluorescent immunohistochemistry with anti
CD45 (blue) and insulin (red) antibodies were used to identify mice pancreatic GFP positive and CD45+ donor cells in GFP negative C57BL6 mice,
which were transplanted with 25610
6 ml GFP positive WBM via tail vein after recipients had 500 cGy irradiation. GFP positive cells (indicated by
narrow arrow) are CD45 negative. CD45 positive cell (indicated by large arrow) is GFP negative. B. CD34 positive cells were further confirmed by
double labeling color immunohistochemistry with anti CD34 antibody (dark blue indicated by black arrow) in islet (brown) stained with anti-insulin
antibody. Image magnification: 640.
doi:10.1371/journal.pone.0004504.g004
Bone Marrow Sca Cells in Islet
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differentiation into insulin positive cells in the recipient’s
islets
Subpopulations of Sca+ cells were pre-cultured with cytokines
IL-3 (50 U/ml), IL-6 (50 ng/ml), IL-11 (50 ng/ml) and steel
(50 ng/ml) for 0, 24 and 48 hours. Cells positive for both GFP and
insulin were only found in the recipient’s pancreas from the
48 hour culture group as shown in Figure 5 immunohistochem-
istry images. Immunohistochemistry with specific anti-insulin
antibody under de-confocal microscopy further confirmed that
insulin positive cells were derived from positive GFP donor
marrow. As viewed in Figure 6 A–D, cultures exposed to cytokines
for 48 hours stimulated bone marrow Sca+ cells to differentiate
into insulin positive cells in the pancreas. The amplified detail in
the cytosol of insulin positive cells shows GFP staining colocalized
with cytosol positive insulin granule staining in (E) and (F) (arrows
indicate GFP positive and insulin granules in cytosol). The insulin
positive granules can be clearly observed in the cellular cytosol of
both GFP positive- insulin positive cells and insulin positive cells.
Discussion
In this study, we found that GFP signals in eGFP animal
pancreatic islets cells were particularly weak. This may be one
reason that there were controversial reports for GFP in islets
[3,13,14] . Therefore, in this study, we used uGFP animals as a
bone marrow donor to avoid the weak GFP signal and focused on
how bone marrow specific lineages, with the combination of
cytokine treatment, influence bone marrow migration to islets and
conversion into insulin positive cells in vivo.
We found that bone marrow cell migration into pancreatic
tissue was restricted vs. migration into the spleen, as shown figure 3
(about 120 folds difference). More GFP positive cells were found in
the outer perimeter of the islets than within the islet, it was 8.5:1 or
about 12% of total population, suggesting that bone marrow
migration into islets is a critical step for bone marrow to contribute
to islet b cell function and regeneration.
After testing six different sorted subpopulations of GFP positive
bone marrow on GFP negative animals, we found that the bone
marrow cell population Sca+/Mac-12 can migrate into islets
more efficiently than WBM and the other five cell subpopulations.
The mechanisms involved may rely on cellular surface chemokine
receptor expression and pancreatic islet releasing factors, in which
activation of chemokine receptors in bone marrow cells promotes
cell migration into the islets [15–17]. On the other hand, Sca+ cell
lineage has the potential to differentiate into insulin positive cells in
vitro and in vivo [18–20]. Although we only found Sca+/Mac-12
favorable in this migration study, we are not excluding the
possibility that other sub populations from bone marrow may also
play a role in islet homing.
Ithasbeen reported that cytokineenrichedbone marrowcultures
alters bone marrow surface markers and improves bone marrow
repopulation [21]. In this study, the Sca+/Mac-1 cell population
was cultured with cytokines before transplantation for 0, 24 and
48 hours, revealing that Sca+ cells treated by cytokines for 48 hours
induced differentiation into insulin positive cells in vivo. This
suggests that cytokines are critical for bone marrow’s participation
in islet b cell function recovery and b cell regeneration. Cytokines
tested in this study include IL-3, 6, 11 and steel factors in vitro.
However, the levels of these factors, or others in vivo, could be
different for individual responses to bone marrow transplantation,
especially in damaged pancreatic animal models.
In summary, the current study provides evidence that transgenic
mouse GFP gene control promoter, bone marrow subpopulation,
and cytokines are critical factors to stimulate successful bone
marrow migration and conversion into insulin-positive cells in
islets in vivo. The phenomenon of cytokine treated bone marrow
Sca+ subpopulations having the ability to migrate and potentially
Figure 5. Lineage population affects bone marrow migration into pancreatic islets. Six different sorted GFP bone marrow populations
were transplanted into GFP negative mice after 500 cGy TBI. The percentage of islets with positive GFP in total pancreatic islets was assayed. The
result shows that favorable bone marrow population for migration into islet is Mac-12/Sca+ vs. WBM (*=p,0.01). (TBM=tested bone marrow).
doi:10.1371/journal.pone.0004504.g005
Bone Marrow Sca Cells in Islet
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mechanistic studies to identify the factors behind this effect.
Supporting Information
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